Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer
| Image |  |
|---|---|
| Description | scientific article published on 10 September 2019 |
| Author/s |
author: Ignace Vergote |
| Publication date | September 10, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |